RibFix Blu Thoracic Fixation System Versus Non-surgical Treatment in Non-flail Chest Rib Fractures
Condition(s) studied
Investigational drug(s) / intervention(s)
Non surgical and Surgical: For non-surgical group, patients will receive non-surgical treatment (analgesia and symptomatic management treatment). For surgical group, patients will receive surgical treatment using RibFix Blu Thoracic Fixation System.
Study summary
This is a prospective, multi-center, observational, cohort study involving skilled cardiothoracic surgeons who are experienced in implanting the treatment of non-flail chest rib fractures and the use of RibFix Blu Thoracic Fixation System.
Eligibility
Primary outcome measure(s)
- Thoracic pain as assessed by numeric Rating Scale (NRS) — 2 weeks
Level of thoracic pain determined using a numeric Rating Scale (NRS). Thoracic pain will be determined using an 11-point Numeric Rating Scale (NRS) in which 0 implicates no pain and 10 the worst pain. If a subject is not able to provide a response to the level of thoracic pain,
Trial sites (5)
| Facility | City | Region | Status |
|---|---|---|---|
| Hunter New England Health District | Sydney | New South Wales | Not Yet Recruiting |
| Flinders Medical Centre | Bedford Park | South Australia | Recruiting |
| The Alfred (Alfred Health) | Melbourne | Victoria | Recruiting |
| Yonsei Wonju Severance Christian Hospital | Wŏnju | Gangwon-do | Recruiting |
| Ajou University Hospital | Suwon | Gyeonggi-do | Recruiting |
More Zimmer Biomet trials in South Korea
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT05146986 on ClinicalTrials.gov ↗ ← All trials in South Korea